| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003551072 |
| P356 | DOI | 10.1186/1479-5876-11-41 |
| P932 | PMC publication ID | 3599141 |
| P698 | PubMed publication ID | 23414367 |
| P5875 | ResearchGate publication ID | 235646579 |
| P2093 | author name string | Hong Wang | |
| Zheng Dong | |||
| Zhen Zeng | |||
| Ke-Qin Hu | |||
| Yong-Ping Yang | |||
| Xiu-Juan Chang | |||
| Yin-Ying Lu | |||
| Jian-Hui Qu | |||
| Chun-Ping Wang | |||
| Lin-Jing An | |||
| Wen-Lin Bai | |||
| Zhong-Xian Xu | |||
| P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | Q29547903 | ||
| Management of hepatocellular carcinoma | Q29616230 | ||
| MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis | Q30157439 | ||
| Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma | Q30460588 | ||
| What are the risk factors for aggravation of esophageal varices in patients with hepatocellular carcinoma? | Q50705503 | ||
| Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. | Q53438311 | ||
| MACC 1 as a marker for vascular invasive hepatocellular carcinoma. | Q54377590 | ||
| MACC1 as a marker for advanced colorectal carcinoma. | Q54416970 | ||
| Serum cytokine levels in response to hepatic cryoablation | Q79548485 | ||
| Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma | Q81381759 | ||
| Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study | Q81455649 | ||
| Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis | Q81868069 | ||
| Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma | Q83899474 | ||
| Technologies for ablation of hepatocellular carcinoma | Q33335561 | ||
| Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. | Q34552875 | ||
| The extent of cryosurgery increases the complication rate after hepatic cryoablation | Q35115319 | ||
| Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma | Q35338422 | ||
| The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma | Q35648702 | ||
| Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis | Q35833031 | ||
| Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors | Q35910539 | ||
| Cryotherapy is associated with improved clinical outcomes of Sorafenib therapy for advanced hepatocellular carcinoma | Q35963024 | ||
| Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma | Q36049932 | ||
| Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations | Q36242739 | ||
| Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. | Q36415612 | ||
| Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma | Q36450499 | ||
| Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials. | Q36476765 | ||
| New aspects of diagnosis and therapy of hepatocellular carcinoma. | Q36519032 | ||
| Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies | Q37263149 | ||
| Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses | Q37325106 | ||
| US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results | Q38001949 | ||
| Cryosurgical ablation of unresectable hepatic tumors | Q41149239 | ||
| Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study | Q42460536 | ||
| The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time | Q42611837 | ||
| Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. | Q43601180 | ||
| Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria | Q44456964 | ||
| Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model | Q44961843 | ||
| Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma. | Q45030295 | ||
| Prognosis predictability of hepatocellular carcinoma according to staging systems in hepatitis B virus-endemic area | Q45359741 | ||
| Regulatory T cells are associated with post-cryoablation prognosis in patients with hepatitis B virus-related hepatocellular carcinoma | Q45376600 | ||
| Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area | Q45400758 | ||
| Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation | Q46089063 | ||
| MACC 1 as a marker for peritoneal-disseminated gastric carcinoma | Q46422794 | ||
| Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival | Q46501630 | ||
| Decrease in size of non-treated lesions after cryoablation for hepatocellular carcinoma | Q47330767 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 41 | |
| P577 | publication date | 2013-02-15 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma | |
| P478 | volume | 11 |
| Q64102475 | ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance |
| Q92645219 | Associations of MACC1, AGR2, and KAI1 expression with the metastasis and prognosis in head and neck squamous cell carcinoma |
| Q89469443 | Correlation of MACC1/c-Myc Expression in Endometrial Carcinoma with Clinical/Pathological Features or Prognosis |
| Q89666821 | Effects of MACC1 polymorphisms on hepatocellular carcinoma development and clinical characteristics |
| Q90319389 | Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma |
| Q36581159 | Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population: A STROBE-Compliant Observational Study |
| Q57816126 | LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells |
| Q98572924 | LncRNA MACC1-AS1/MACC1 enhances the progression of glioma via regulating metabolic plasticity |
| Q38118345 | MACC1 - a novel target for solid cancers |
| Q46190999 | MACC1 overexpression and survival in solid tumors: a meta-analysis |
| Q31166732 | Metastasis-associated in colon cancer 1 is a novel survival-related biomarker for human patients with renal pelvis carcinoma |
| Q41701933 | Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer |
| Q36189115 | Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer |
| Q38833904 | MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line |
| Q64120347 | MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer |
| Q45991279 | Overexpression of MACC1 protein and its clinical implications in patients with glioma. |
| Q35674406 | Prognostic Value of MACC1 in Digestive System Neoplasms: A Systematic Review and Meta-Analysis |
| Q38541281 | Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis. |
| Q37488673 | Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation |
| Q37374584 | The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance |
| Q92617692 | The expression of metastasis-associated in colon cancer-1, Snail, and KAI1 in esophageal carcinoma and their clinical significance |
| Q28066094 | The potential therapeutic applications and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) in cancers |
Search more.